Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward

Lukman Lawal; Munira Aminu Bello; Tonderai Murwira; Clement Avoka; Shamsuddeen Yusuf Ma'aruf; Imoetin Harrison Omonhinmin; Pamela Maluleke; Christos Tsagkaris; Helen Onyeaka

doi:10.1080/21645515.2022.2034457

Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward

Lukman Lawal, Munira Aminu Bello, Tonderai Murwira^*, Clement Avoka, Shamsuddeen Yusuf Ma'aruf, Imoetin Harrison Omonhinmin, Pamela Maluleke, Christos Tsagkaris, Helen Onyeaka

^*Corresponding author for this work

Chemical Engineering

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

94 Downloads (Pure)

Abstract

Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.

Original language	English
Article number	2034457
Number of pages	6
Journal	Human Vaccines and Immunotherapeutics
Volume	18
Issue number	1
DOIs	https://doi.org/10.1080/21645515.2022.2034457
Publication status	Published - 3 Mar 2022

Bibliographical note

Funding Information:
The author(s) reported there is no funding associated with the work featured in this article. We are thankful to Prof. T.M Akande for reviewing this project. We appreciate Melody Okereke for providing insights to this project.

Publisher Copyright:
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

Keywords

Africa
COVID-19 pandemic
COVID-19 vaccination
Covid-19 vaccine inequity
developing countries
disparities
LMIC
low coverage of vaccine
SARS-COV-2
vaccine hesitancy

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/21645515.2022.2034457Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

LawalL2022LowFinal published version, 688 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{38af5e64d1ef47e1b37bbbf174cf73ef,

title = "Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward",

abstract = "Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.",

keywords = "Africa, COVID-19 pandemic, COVID-19 vaccination, Covid-19 vaccine inequity, developing countries, disparities, LMIC, low coverage of vaccine, SARS-COV-2, vaccine hesitancy",

author = "Lukman Lawal and {Aminu Bello}, Munira and Tonderai Murwira and Clement Avoka and {Yusuf Ma'aruf}, Shamsuddeen and {Harrison Omonhinmin}, Imoetin and Pamela Maluleke and Christos Tsagkaris and Helen Onyeaka",

note = "Funding Information: The author(s) reported there is no funding associated with the work featured in this article. We are thankful to Prof. T.M Akande for reviewing this project. We appreciate Melody Okereke for providing insights to this project. Publisher Copyright: {\textcopyright} 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.",

year = "2022",

month = mar,

day = "3",

doi = "10.1080/21645515.2022.2034457",

language = "English",

volume = "18",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Low coverage of COVID-19 vaccines in Africa

T2 - current evidence and the way forward

AU - Lawal, Lukman

AU - Aminu Bello, Munira

AU - Murwira, Tonderai

AU - Avoka, Clement

AU - Yusuf Ma'aruf, Shamsuddeen

AU - Harrison Omonhinmin, Imoetin

AU - Maluleke, Pamela

AU - Tsagkaris, Christos

AU - Onyeaka, Helen

N1 - Funding Information: The author(s) reported there is no funding associated with the work featured in this article. We are thankful to Prof. T.M Akande for reviewing this project. We appreciate Melody Okereke for providing insights to this project. Publisher Copyright: © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

PY - 2022/3/3

Y1 - 2022/3/3

N2 - Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.

AB - Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.

KW - Africa

KW - COVID-19 pandemic

KW - COVID-19 vaccination

KW - Covid-19 vaccine inequity

KW - developing countries

KW - disparities

KW - LMIC

KW - low coverage of vaccine

KW - SARS-COV-2

KW - vaccine hesitancy

UR - http://www.scopus.com/inward/record.url?scp=85125996125&partnerID=8YFLogxK

U2 - 10.1080/21645515.2022.2034457

DO - 10.1080/21645515.2022.2034457

M3 - Article

C2 - 35240908

AN - SCOPUS:85125996125

SN - 2164-5515

VL - 18

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

M1 - 2034457

ER -

Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this